TABLE 1.
Patients’ Clinical and Surgicopathologic Characteristics
| Characteristic | Value |
|---|---|
| No. of patients | 52 |
| Age at MRI (y), median (range) | 66 (43–80) |
| PSA level at MRI (ng/mL), mean (95% CI) | 2.2 (1.3–3.2) |
| Time between RP and MRI (mo), mean (95% CI) | 85 (75.6–107.2) |
| Time between MRI and biopsy (d), mean (95% CI) | 15 (6.2–24.9) |
| Gleason score at prostatectomy (no. of patients) | |
| G6 (3 + 3) | 8 |
| G7 (3 + 4, n = 13; 4 + 3, n = 11) | 24 |
| G8 (4 + 4, n = 5; 5 + 3, n = 2) | 7 |
| G9 (4 + 5, n = 8; 5 + 4, n = 2) | 10 |
| Unknown | 3a |
| Positive surgical margins (no. of patients) | 17 |
| Extracapsular extension (no. of patients) | 24 |
| Seminal vesicle invasion (no. of patients) | 11 |
Note—PSA = prostate-specific antigen, RP = radical prostatectomy.
a
Histopathologic reports listing pathologic stage were not available for three patients included in the study because they underwent RP at a different institution.